In Vivo Lead

The In Vivo Lead will drive the design, execution, and interpretation of in vivo studies supporting radiopharmaceutical drug discovery and development programs at ARTBIO. This individual will provide both scientific and operational leadership, mentor team members, and ensure the generation of high-quality, timely data to inform key development decisions. The role requires close cross-functional collaboration with radiochemistry, biology, and discovery teams to define and advance the vision and capabilities for the vivo discipline at ARTBIO.

Targeted alpha-particle radiotherapy company developing next-gen cancer treatments. Based in New York, NY.

artbio.com